Fennec Pharmaceuticals Inc. · NASDAQ:FENC

Rosalind Advisors, Inc. reported a 7.50% stake in Fennec Pharmaceuticals Inc. (Schedule 13G)

Event Sep 30, 2025 · Filed Nov 13, 2025

Rosalind Advisors, Inc. reported a 7.50% stake in Fennec Pharmaceuticals Inc., 2,076,840 shares, as a passive investor on Sep 30, 2025. Filed Nov 13, 2025 (Schedule 13G).

Stake
7.50%
Shares
2,076,840
Intent
Passive
What changed
Crossed above 5%
Filed together
4 holders

The filing in full

HolderStakeShares
Rosalind Advisors, Inc.7.50%2,076,840
SALAMON STEVEN A J7.50%2,076,840
Aharon Gil7.50%2,076,840
Rosalind Master Fund L.P.7.50%2,076,840

Source

View original at SEC

Related